Skip to main content

Table 1 Characteristics of breast cancer case-patient participants and control participants by study

From: Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis

 

Overall

Women’s CARE Study

Women’s BCIS Study

Women’s LIFE Study

Number of cases (%)

Number of controls (%)

Number of cases (%)

Number of controlsa (%)

Number of cases (%)

Number of cases (%)

Number of controls (%)

Number of participants

3934

2386

1873

1982

517

1544

404

Subtype of breast cancer

 Unclassified

1151

691

182

278

 Classified

2783

1182

335

1266

  Triple negative (ER–/PR–/HER2–)

515 (18.5)

329 (27.8)

21 (6.3)

165 (13.0)

  Luminal-like (ER+ and/or PR+)

2056 (73.9)

 

758 (64.1)

 

277 (82.7)

1021 (80.7)

 

  HER2-enriched (ER–/PR–/HER2+)

212 (7.6)

95 (8.0)

37 (11.0)

80 (6.3)

Mean age at reference date, years (SD)

47.3 (7.4)

47.9 (8.1)

48.9 (8.5)

48.8 (8.4)

51.5 (7.3)

44.0 (3.9)

43.5 (3.8)

Menopausal status

 Premenopausal

2427 (61.7)

1257 (52.7)

929 (49.6)

927 (46.8)

203 (39.3)

1295 (83.9)

330 (81.7)

 Postmenopausal

1507 (38.3)

1129 (47.3)

944 (50.4)

1055 (53.2)

314 (60.7)

249 (16.1)

74 (18.3)

  Never used MHT

650 (43.1)

466 (41.3)

409 (43.3)

430 (40.8)

107 (34.1)

134 (53.8)

36 (48.7)

  Ever used MHT

857 (56.9)

663 (58.7)

535 (56.7)

625 (59.2)

207 (65.9)

115 (46.2)

38 (51.3)

Race

 White

2849 (72.4)

1503 (63.0)

1056 (56.4)

1134 (57.2)

435 (84.1)

1358 (88.0)

369 (91.3)

 African-American

1085 (27.6)

883 (37.0)

817 (43.6)

848 (42.8)

82 (15.9)

186 (12.0)

35 (8.7)

BMI at age 18 years, kg/m2

 < 20.0

1921 (48.8)

1110 (46.5)

882 (47.1)

906 (45.7)

286 (55.3)

753 (48.8)

204 (50.5)

 20.0–24.9

1740 (44.2)

1061 (44.5)

848 (45.3)

893 (45.1)

207 (40.0)

685 (44.4)

168 (41.6)

 ≥ 25.0

273 (6.9)

215 (9.0)

143 (7.6)

183 (9.2)

24 (4.6)

106 (6.9)

32 (7.9)

Recent BMI, kg/m2

 < 25.0

2292 (58.3)

1271 (53.3)

985 (52.6)

1003 (50.6)

345 (66.7)

962 (62.3)

268 (66.3)

 25.0–29.9

968 (24.6)

652 (27.3)

511 (27.3)

570 (28.8)

115 (22.2)

342 (22.2)

82 (20.3)

 ≥ 30.0

674 (17.1)

463 (19.4)

377 (20.1)

409 (20.6)

57 (11.0)

240 (15.5)

54 (13.4)

  1. Abbreviations: ER estrogen receptor, PR progesterone receptor, HER2, human epidermal growth factor receptor-2, BMI body mass index, CARE Contraceptive and Reproductive Experiences, BCIS Breast Carcinoma in situ, LIFE Learning the Influence of Family and Environment, MHT menopausal hormone therapy
  2. aIncluding those who also served as controls for the Women’s BCIS Study